Benmelstobart (TQB2450) combined with anlotinib hydrochloride capsule in the treatment of advanced, recurrent, or metastatic endometrial cancer: A multicohort, open label, multicenter, phase II clinical trial (TQB2450-II-08).
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-04-30 18:47:45 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1200/jco.2024.42.16_suppl.5593
文献链接: https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.5593
其他信息:
出版社: American Society of Clinical Oncology (ASCO)
作者: Xiaohua Wu; Xiaojun Chen; Ke Wang; Dong Wang; Ruifang An; Jianqing Hou; Ying Yang; Danbo Wang; Pengpeng Qu; Bingzhong Zhang; Wei Duan; Xiumin Li; Ai-min Zang; Guohua Yu; Hanmei Lou; Desheng Yao; Shuzhen Wang; Dong Yan; Liang Li; Xiaowei Liu

